BlackRock Inc. - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 8 filers reported holding MONOPAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$5,000
-85.7%
2,327
-83.0%
0.00%
Q1 2022$35,000
-23.9%
13,717
-3.9%
0.00%
Q4 2021$46,000
-32.4%
14,275
+2.2%
0.00%
Q3 2021$68,000
-23.6%
13,965
-7.2%
0.00%
Q2 2021$89,000
+27.1%
15,046
+34.0%
0.00%
Q1 2021$70,000
+112.1%
11,229
+108.3%
0.00%
Q4 2020$33,000
+135.7%
5,391
+99.4%
0.00%
Q3 2020$14,000
-48.1%
2,703
-25.6%
0.00%
Q2 2020$27,000
+35.0%
3,632
+29.5%
0.00%
Q1 2020$20,0002,8040.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Windsor Advisory Group, LLC 89,974$55,7750.13%
Rappaport Reiches Capital Management, LLC 10,695$6,6300.00%
Tower Research Capital LLC (TRC) 3,727$2,3110.00%
JPMORGAN CHASE & CO 4$20.00%
VANGUARD GROUP INC 87,596$54,3010.00%
UBS Group AG 72$450.00%
WELLS FARGO & COMPANY/MN 33$200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 41,199$23,4830.00%
MILLENNIUM MANAGEMENT LLC 19,008$10,8350.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders